General

TB500 Frag 17-23 is a truncated peptide fragment derived from thymosin beta-4, specifically targeting the region responsible for its anti-inflammatory and tissue-repairing effects. This fragment is believed to promote wound healing, reduce inflammation, and enhance cellular regeneration, similar to the full-length thymosin beta-4 peptide, but with potentially fewer side effects. While research on TB500 Frag 17-23 is still in its early stages, it shows promise for therapeutic applications in tissue repair and recovery.

Please note: We offer both TB500 (Frag 17-23) and TB500 (Thymosin Beta 4) and they are chemically different.  In some cases, other wholesalers offer TB500 without any notation of which format.  Please confirm your research requirements prior to ordering.

Chemical Properties